Shopping Cart
- Remove All
- Your shopping cart is currently empty
ME-143, a second-generation tumor-specific NADH oxidase inhibitor, exhibits efficacy by inhibiting the WNT/β-catenin pathway in colorectal cancer cells. Demonstrating broad activity against cancers both in vitro and in vivo, this compound presents a promising therapeutic avenue.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | ME-143, a second-generation tumor-specific NADH oxidase inhibitor, exhibits efficacy by inhibiting the WNT/β-catenin pathway in colorectal cancer cells. Demonstrating broad activity against cancers both in vitro and in vivo, this compound presents a promising therapeutic avenue. |
Alias | NV-143 |
Molecular Weight | 334.37 |
Formula | C21H18O4 |
Cas No. | 852536-39-1 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.